search icon

    Market Snapshot

    • S&P Futures

      4,146

    • Dow Futures

      32,829

    • Nasdaq Futures

      13,193.75

    blog search icon

    Global Blood Therapeutics, Inc.

    (NASDAQ:GBT)

    $66.60

    $2.76

    4.32%

    Global Blood Therapeutics, Inc. Chart

    GBT Stock Price Today

    Global Blood Therapeutics, Inc. (GBT) stock rallied over 4.32% intraday to trade at $66.6 a share on NASDAQ. The stock opened with a gain of 40.48% at $66.69 and touched an intraday high of $66.77, rising 4.32% against the last close of $63.84. The stock went to a low of $66.545 during the session.

    Stock Snapshot

    $63.84

    Prev. Close

    3.26 Billion

    Market Cap

    $66.545

    Day Low

    $66.69

    Open

    64.84 Million

    Number of Shares

    $66.77

    Day High

    -

    P/E ratio

    -4.86

    EPS (TTM)

    8.50

    Cash Flow per Share

    15.53

    Free Float in %

    4.79

    Book Value

    39,300,793

    Volume

    Global Blood Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$66.69$66.77$66.545$66.61534,026,350
    2022-08-05$47.41$73.02$46.572$63.8413,968,900
    2022-08-04$44.1$48.49$43.53$47.998,854,600
    2022-08-03$33.4$34.82$33.38$33.931,478,900
    2022-08-02$32.34$33.23$32.1$32.93665,500
    2022-08-01$31.51$33.645$31.51$32.4891,400
    2022-07-29$32.43$32.81$31.58$32.72802,500
    2022-07-28$33.86$34.578$32.21$32.73714,000
    2022-07-27$33.44$34.42$32.94$34.031,264,100
    2022-07-26$33.46$34.03$32.426$33.35883,100

    Contact Details

    181 Oyster Point Boulevard
    South San Francisco, CA 94080
    United States

    Webiste:GBT

    650 741 7700

    Company Information

    Employees-

    Beta0.83

    Sales or Revenue210.87 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

    Frequently Asked Questions

    icon

    What is the current Global Blood Therapeutics, Inc. (GBT) stock price?

    Global Blood Therapeutics, Inc. (NASDAQ: GBT) stock price is $66.6 as of the last check on Monday, August 8. During the trading session, GBT stock reached the peak price of $66.77 while $66.545 was the lowest point it dropped to.

    icon

    GBT's industry and sector of operation?

    The NASDAQ listed GBT is part of Biotechnology industry that operates in the broader Health Care sector. Global Blood Therapeutics, Inc. , a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD).

    icon

    Who are the executives of GBT?

    Ms. Nazila Habibizad
    Sr. VP of Operations
    Dr. Ted W. Love M.D.
    Pres, CEO & Director
    Mr. Jeffrey S. Farrow
    CFO & Principal Accounting Officer
    Ms. Patricia Borga Suvari
    Chief Legal Officer & Sec.

    icon

    What is the GBT stock price today?

    GBT stock traded closed the last session at $66.615, which is $2.759999999999991 or 4.32% lower than its previous close of $63.84. GBT's current trading price is 207.62% lower than its 52-week high of $73.02 where as its distance from 52-week low of 21.65% is -8.79%.

    icon

    How many employees does GBT have?

    Number of GBT employees currently stands at -. GBT operates from 181 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

    icon

    Link for GBT official website?

    Official Webiste of $GBT is: https://www.gbt.com

    icon

    How do I contact GBT?

    GBT could be contacted at GBT operates from 181 Oyster Point Boulevard, South San Francisco, CA 94080, United States, or at phone #650 741 7700 and can also be accessed through its website.

    icon

    How many shares of GBT are traded daily?

    GBT stock volume for the day was 39,300,793 shares while in the previous session number of GBT shares traded was 34,026,350 . The average number of GBT shares traded daily for last 3 months was 1.82 Million.

    icon

    How much did GBT change today?

    The percentage change in GBT stock occurred in the recent session was 4.32% while the dollar amount for the price change in GBT stock was $2.759999999999991.

    icon

    What price range GBT stock been trading in?

    In the recent session, the day high for GBT stock was $66.77 while the low for GBT stock touched on the day was $66.545.

    icon

    What is the market cap of GBT currently?

    The market value of GBT currently stands at 3.26 Billion with its latest stock price at $66.6 and 64.84 Million of its shares outstanding.